2nd Quarter - Report

GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$330,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Organ donation issues, including the liver transplant allocation system and in support of new proposed UNOS system; support Ebola funding for hospital preparedness and treatment activities, including NY delegation letter to HHS and calls to HHS and meetings with Administration officials.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
BRUCE C VLADECK —
SUSAN C WALTMAN —
ELISABETH R WYNN —

Contacted: SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Graduate Medical Education (GME) issues (including Resident Physician Shortage Reduction Act (H.R.2124/S.1148) - support); provided comments to Congress in response to Energy and Commerce Committee request for input on GME; amendments to the Medicare hospital re-admissions penalty program methodology (providing SES adjustments, fixing the formula flaw), H.R.1343/S.688 - support; proposals to amend the 2 midnight policy - support; hospital issues included in President Obama's FY 16 budget - oppose; hospital issues included in H.R.2, the Medicare Access and CHIP Re-authorization Act of 2015 - support; legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; Strengthening Medicare Advantage through Innovation and Transparency for Seniors (H.R.2570) - oppose; Medicare Inpatient Prospective Payment System FY 2016 proposed rule (CMS 1632-P) - detailed comment letter; legislation to improve the recovery audit contractor program (H.R.2156); Audit and Appeal Fairness, Integrity and Reforms in Medicare Act (AFIRM) - provided comments to the Senate Finance Committee; Ensuring Seniors Access to Local Pharmacies Act of 2015 (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Act (S.776) - support; CMS-4159-F2 - comments on daily dispensing fees.

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS)

Bills named: S. 1148 (114th), H.R. 793 (114th), H.R. 2124 (114th), S. 314 (114th), H.R. 2 (114th), S. 776 (114th), S. 1190 (114th), H.R. 605 (114th), H.R. 244 (114th), H.R. 1343 (114th), H.R. 2570 (114th), S. 275 (114th), S. 688 (114th), H.R. 2156 (114th)

Pharmacy PHA

Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including implementation of the Drug Quality and Security Act (P.L.113-54) and P.L.112-144; support medical device pricing transparency and prohibition on medical device price "gag clauses"; preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases; pharmaceutical labeling of generic drugs (FDA-2013-N-0500); legislation to create a comprehensive Medicare home infusion benefit (H.R.605/S.275) - support; support reforming the durable medical equipment competitive bidding program; supporting "any willing pharmacy" legislation; promoting access to biosimilars (labeling/interchangeability); 21st Century Cures Act (H.R.6) - general support for overall bill, support final pharmacy lock-in policy, oppose PPSA weakening of existing requirements, oppose Section 4004 treatment of infusion drugs furnished through durable medical equipment; Ensuring Seniors Access to Local Pharmacies Act (H.R.793/S.1190) - support; Pharmacy and Medically Underserved Areas Enhancement Act (S.314) - support; MAC Transparency Act (H.R.244) - support; Medication Therapy Management Empowerment Act (S.776) - support; Strengthening Medicare Advantage Through Innovation and Transparency for Seniors - oppose; FDA-2014-D-1524 - comments on draft guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities; FDA-2014-N-1459 - comments on draft MOU addressing certain distributions of compounded human drug products between states and the FDA; proposed changes to the 340B prescription drug program - oppose

LobbyistCovered position, as disclosed
JONATHAN COOPER —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
SHARA SIEGEL New —
AISLING WARDE ZACCARELLI —

Contacted: Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 605 (114th), S. 1190 (114th), H.R. 244 (114th), S. 314 (114th), H.R. 793 (114th), S. 776 (114th), S. 275 (114th), H.R. 6 (114th)

Insurance INS

Support House and Senate proposal for re-authorization of the Terrorism Risk Insurance Act (H.R.26).

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —

Contacted: Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 26 (114th)

Budget/Appropriations BUD

House and Senate Budget Resolutions, provisions relating to Medicare reductions - oppose (H.Con.Res. 27, S.Con.Res.11)

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —

Contacted: Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); White House Office; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S.Con.Res. 11 (114th), H.Con.Res. 27 (114th)

Affiliated organisations

OrganisationLocation
GNYHA SERVICES, INC. New York, NY, US
GNYHA VENTURES, INC. New York, NY, US
INNOVATIX, LLC New York, NY, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.